Skip to main content
TECON BIOLOGY Co.LTD logo

TECON BIOLOGY Co.LTD — Investor Relations & Filings

Ticker · 002100 ISIN · CNE000001PZ9 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,493 across all filing types
Latest filing 2022-04-26 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 002100

About TECON BIOLOGY Co.LTD

https://www.tcsw.com.cn

TECON BIOLOGY Co.LTD operates an integrated industrial chain focused on animal health and nutrition. The company specializes in the research, development, and manufacturing of veterinary biological products, including a comprehensive range of vaccines and diagnostic reagents for livestock. Its operations encompass the production of high-quality animal feed and the management of large-scale breeding programs, with a primary focus on pig farming and meat processing. By leveraging advanced biotechnology and standardized production systems, the company provides comprehensive solutions for livestock management and food safety. Key activities include the formulation of specialized animal nutrition products and the implementation of rigorous biosecurity protocols across its facilities to ensure the quality and reliability of its agricultural outputs.

Recent filings

Filing Released Lang Actions
年度关联方资金占用专项审计报告
Regulatory Filings
2022-04-26 Chinese
新疆星河律师事务所关于天康生物股份有限公司2022年第二次临时股东大会之法律意见书
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding the convening, attendance, and voting procedures of the 2022 second extraordinary general meeting (临时股东大会) of Tian Kang Bio. It details the legality of the meeting's call, the qualifications of attendees, and the voting results. The document is not a report of financial results, audit, or management discussion, nor is it a simple announcement or certification. It is a legal opinion related to a shareholders' meeting, which is a specialized document type. Given the content and nature, it fits best under the category of Declaration of Voting Results & Voting Rights Announcements (DVA), as it includes voting results and legal validation of the meeting and voting process.
2022-04-12 Chinese
2022年第二次临时股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled as a resolution announcement for the "2022 Second Extraordinary General Meeting of Shareholders" of Tian Kang Biological Co., Ltd. It details the meeting date, attendance, voting results on financing and guarantee proposals, and includes a legal opinion from a law firm confirming the legality of the meeting and resolutions. The document is relatively short (2085 characters) and focuses on the official announcement of shareholder meeting resolutions and voting outcomes. There is no detailed financial data, management discussion, or full report content. This matches the definition of a Declaration of Voting Results & Voting Rights Announcement (DVA).
2022-04-12 Chinese
关于2022年3月份生猪销售简报
Regulatory Filings Classification · 70% confidence The document is a sales brief for March 2022 from Tian Kang Biological Co., Ltd., detailing sales volume and revenue of live pigs. It includes month-over-month and year-over-year comparisons, reasons for sales changes, and risk warnings. The document is short (899 characters) and provides a snapshot of sales performance rather than comprehensive financial statements or detailed analysis. It is not an earnings release since it lacks key financial highlights or quarterly results, nor is it an annual or interim report. It is also not a regulatory filing, management report, or investor presentation. The document is a brief operational update focused on sales data for a specific month, which fits best under the category of a Capital/Financing Update (CAP) as it relates to sales performance and revenue updates. However, since it is specifically a sales brief and not a financing or capital structure update, the closest fitting category is Regulatory Filings (RNS) as a general announcement. Given the document's nature and length, the best classification is Regulatory Filings (RNS) with moderate confidence.
2022-04-08 Chinese
关于获得中国合格评定国家认可委员会（CNAS）实验室认可证书的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from Tian Kang Biological Co., Ltd. about obtaining a laboratory accreditation certificate from the China National Accreditation Service (CNAS). It describes the certificate details, effective dates, and the significance of the accreditation. There is no financial data, no mention of financial results, no regulatory filings or voting results, and no indication of a report being attached or published. The document is a regulatory announcement about a certification achievement, which does not fit into financial report categories like Annual Report, Interim Report, or Earnings Release. It is not a report publication announcement either, as it does not mention any report release. The best fitting category is Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory announcements that do not fit other categories.
2022-04-06 Chinese
2022年第一季度可转换公司债券转股情况的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the convertible bonds (可转换公司债券) of Tian Kang Bio Co., Ltd. It details the bond issuance, conversion prices, conversion periods, and changes in shareholding due to bond conversions during the first quarter of 2022. It includes specific data on bond conversion amounts, share changes, and regulatory approvals. The document is titled as an "announcement" (公告) and provides detailed information about bond conversion and shareholding changes, which is typical for a Capital/Financing Update. It is not a full financial report like an Annual or Interim Report, nor is it a simple notification of voting results or a regulatory filing. The length is 2567 characters, which is relatively short but contains substantive financial and capital structure information related to convertible bonds and share capital changes. Therefore, the most appropriate classification is Capital/Financing Update (CAP).
2022-04-01 Chinese

Browse filings by year

21 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.